№ lp_2_1_14213
File format: docx
Character count: 2467
File size: 86 KB
A document outlining the conditions and requirements for accessing a platform for large-scale cell-free protein/RNA expression, including necessary certifications and technical specifications.
Note:
Year
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
Europe
Subject:
Product Information
Document Type:
Summary of Product Characteristics
Organization / Institution:
European Medicines Agency
Author:
European Medicines Agency
Target Audience:
Healthcare professionals
Period of Validity:
Ongoing
Approval Date:
2026
Date of Changes:
2026
Year:
2023
Region / City:
Seoul, Republic of Korea
Topic:
Biotechnology, Enzyme Engineering
Document Type:
Research Supplementary Information
Institution:
Korea University, Sogang University
Authors:
Yeonhwa Yu, Yongfan Shi, Young Wan Kwon, Yoobin Choi, Yusik Kim, Jeong-Geol Na, June Huh, Jeewon Lee
Target Audience:
Researchers in Chemical and Biological Engineering, Biotechnology
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Contextual Description
Year:
2026
Region / city:
United States of America
Topic:
Protein structures, Tardigrades, Dehydration tolerance
Document Type:
Research Article
Author:
Claire K. Zhang, Qi Zhang
Target Audience:
Researchers in molecular biology, biochemistry, and extremophiles
Period of Effect:
Not specified
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2017–2018
Region / City:
Ilorin, Kwara State, Nigeria
Topic:
Hematology / Iron Status
Document Type:
Original Research Article
Institution:
University of Ilorin Teaching Hospital
Author:
Not specified
Target Population:
Healthy Nigerian adults aged 18–70
Sample Size:
112 participants
Methods:
Cross-sectional study, full blood count, ELISA for serum ferritin and soluble transferrin receptor, TSAT calculation
Inclusion Criteria:
Adults aged 18–70 with consent
Exclusion Criteria:
Hematinics use, blood donors, recent transfusion, febrile illness
Statistical Analysis:
SPSS version 22.0, p-value < 0.05
Reference Ranges Established:
Serum ferritin 20.0–218.4 ng/ml, TSAT 21.5–47.4%, sTfR 8.8–26.9 nmol/L
Year:
2012–2013
Region / City:
United States, West Lafayette, IN and Phoenix, AZ
Topic:
Nutrition, Bone Health, Microbiome
Document Type:
Research Article
Institution:
Arizona State University, Purdue University
Authors:
Corrie M Whisner, Berdine R Martin, Cindy H Nakatsu, Jon A Story, Claire J MacDonald-Clarke, Linda D McCabe, George P McCabe, Connie M Weaver
Target Audience:
Adolescent females
Study Design:
Randomized, double-blind, cross-over, dose-response trial
Intervention:
Soluble corn fiber (SCF) supplementation at 0, 10, 20 g/d
Primary Outcome:
Calcium absorption efficiency
Secondary Outcomes:
Fecal microbial composition, short chain fatty acid production, fecal pH
Support:
Tate & Lyle Ingredients Americas LLC
Conflicts of Interest:
Connie M Weaver is Advisory Board Member for Pharmavite; other authors declared no conflicts
Clinical Trial Registration:
Clinicaltrials.gov NCT01660503
Figures:
5
Tables:
4
Year:
2026
Region / city:
Darmstadt, Germany
Topic:
RNA Aptamers, SELEX, Homooriodictyol
Document type:
Research article
Organization / institution:
TU Darmstadt
Author:
Janis Hoetzel, Cristina Bofill-Bosch, Andres W. Martinez, Martin M. Rudolph, Florian Groher, Beatrix Suess
Target audience:
Researchers, biochemists, molecular biologists
Date of approval:
2026
Date of changes:
2026
Note:
Contextual description
Year:
2021
Region / City:
Not specified
Topic:
RNA Extraction
Document Type:
Standard Operating Procedure (SOP)
Organization:
Not specified
Author:
Subash Kumar Rai
Target Audience:
Laboratory Personnel
Effective Date:
28 Oct 2021
Date of Approval:
28 Oct 2021
Date of Last Review:
Not specified
Period of Validity:
Indefinite
Date of Revision:
Not specified
Year:
2016
Region / city:
Sydney
Subject:
DNA/RNA extraction, laboratory safety
Document type:
Standard Operating Procedure
Organization:
The University of Sydney
Author:
Coleman, N.; Nikolic, A.
Target audience:
Laboratory personnel, researchers
Period of validity:
Ongoing
Approval date:
Not specified
Modification date:
Not specified
Year:
2015
Region / city:
Global
Topic:
RNA extraction, clinical samples, FTA cards
Document Type:
Protocol
Organization:
CDC, GMRLN, WHO
Author:
CDC
Target Audience:
Laboratory professionals
Period of validity:
N/A
Approval Date:
01/27/2015
Date of Changes:
N/A
Note:
Year
Topic:
Gene Editing
Document Type:
Cheat Sheet
Target Audience:
Educators, Researchers in Genetics
Year:
2023
Region / City:
Not specified
Topic:
DNA and RNA isolation protocols
Document Type:
Supplementary Data
Author:
Not specified
Target Audience:
Researchers in molecular biology and genomics
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2007-2008
Region / City:
Yucatan Peninsula, Mexico
Topic:
Virus discovery, Mosquitoes, Metagenomics
Document type:
Research Article
Organization / Institution:
Iowa State University, University of Cambridge, Universidad Autónoma de Yucatán
Author:
Jermilia Charles, Chandra S. Tangudu, Stefanie L. Hurt, Charlotte Tumescheit, Andrew E. Firth, Julian E. Garcia-Rejon, Carlos Machain-Williams, Bradley J. Blitvich
Target Audience:
Researchers, Academics, Microbiologists
Period of Validity:
Not applicable
Approval Date:
Not mentioned
Date of Changes:
Not applicable
Year:
2020
Region / City:
New South Wales, Australia
Topic:
Biology, SARS-CoV-2, RNA, Vaccination, Infectious Diseases
Document Type:
Educational Resource
Organization / Institution:
New South Wales Education Standards Authority (NESA)
Author:
Not specified
Target Audience:
Year 12 students
Period of Validity:
2020 and onwards
Approval Date:
2017
Date of Changes:
Not specified
Year:
2023
Region / City:
Ohio, USA
Topic:
Nanotechnology, RNA Nanoparticles, Cancer Targeting
Document Type:
Research Article
Organization / Institution:
The Ohio State University, Wexner Medical Center
Author:
Hongzhi Wang, Chiran Ghimire, Hui Li, Mario Vieweger, Congcong Xu, Peixuan Guo
Target Audience:
Researchers, Scientists, Medical Professionals
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Context
Year:
2010
Region / City:
N/A
Subject:
Biomedical Research, Cell Biology, Molecular Biology
Document Type:
Research Methods Supplement
Author:
N/A
Target Audience:
Researchers, Scientists in Biomedical Fields
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year of completion:
2023
Field:
Cancer research and tumor immunology
Research focus:
PPP2R2A deletion and expression in NSCLC and immunotherapy response
Type of document:
Supplementary materials and methods section of a scientific study
Data sources:
cBioPortal Pan-Lung cancer dataset; TCGA pan-cancer RNA-Seq data via Xena Browser; Kmplot survival database
Cell lines:
A549 cells; CMT167 PPP2R2A heterozygous knockout cells
Animal models:
CD11b-DTR mice (Jackson Laboratory, strain 006000); C57BL6 mice
Experimental techniques:
RNA sequencing; Gene Set Enrichment Analysis (GSEA); glycosylation assays with PNGase F and Endo H; adoptive Treg transfer; flow cytometry; Treg suppression assay with CellTrace Violet; ELISA
Repositories:
NCBI GEO (accession number GSE311238)
Analytes:
PD-L1, TNF-α, IFN-γ, IFN-α, IFN-β
Antibodies and reagents:
Anti-Mouse PD-L1 In Vivo Antibody (Clone 10F.9G2, Ichorbio); reagents from BioLegend, STEMCELL Technologies, eBioscience, R&D Systems, PBL Assay Science
Cited works:
Gyorffy B., 2024, Innovation (Camb); Qiu Z. et al., 2020, Cancer Research; Zhou L. et al., 2024, Journal of Clinical Investigation
Year:
2021
Region / City:
Ann Arbor, MI, USA
Subject:
Structural Biology, RNA Biomedicine
Document Type:
Research Paper
Organization:
University of Michigan, Life Sciences Institute, Single Molecule Analysis Group, Biophysics Program
Authors:
Adrien Chauvier, Jason C. Porta, Indrajit Deb, Emily Ellinger, Aaron T. Frank, Melanie D. Ohi, Nils G. Walter
Target Audience:
Researchers in the field of biochemistry and molecular biology
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2023
Region / City:
Edinburgh, UK; Boston, Massachusetts, USA
Topic:
Kidney disease, RNA sequencing
Document Type:
Research Letter
Organization / Institution:
Royal Infirmary of Edinburgh, University of Edinburgh, Brigham and Women’s Hospital, Harvard Medical School
Author:
Eoin D O’Sullivan MD, Katie J Mylonas PhD, David A Ferenbach MD PhD
Target Audience:
Researchers in renal medicine and RNA sequencing
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A